Neurology Minute
By American Academy of Neurology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by American Academy of Neurology
Category: Mental Health
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 79
Reviews: 0
Episodes: 1000
Description
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
| Episode | Date |
|---|---|
|
Lifestyle Interventions for Global Cognitive Function
|
Oct 17, 2025 |
|
TOAST Criteria: Time is Brain, or Brain is TOAST – Part 2
|
Oct 16, 2025 |
|
TOAST Criteria: Time is Brain, or Brain is TOAST – Part 1
|
Oct 15, 2025 |
|
Measles - Part 5
|
Oct 14, 2025 |
|
Measles - Part 4
|
Oct 13, 2025 |
|
Updates in Idiopathic Intracranial Hypertension
|
Oct 10, 2025 |
|
General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes
|
Oct 09, 2025 |
|
October 2025 President Spotlight: Critical Importance of Research
|
Oct 08, 2025 |
|
October 2025 Capitol Hill Report: Government Shutdown
|
Oct 07, 2025 |
|
WHO Launches New Technical Brief on Encephalitis - Part 2
|
Oct 06, 2025 |
|
WHO Launches New Technical Brief on Encephalitis - Part 1
|
Oct 03, 2025 |
|
Measles - Part 3
|
Oct 02, 2025 |
|
Measles - Part 3
|
Oct 02, 2025 |
|
Measles - Part 2
|
Oct 01, 2025 |
|
Measles - Part 1
|
Sep 30, 2025 |
|
September 2025 Capitol Hill Report: BrainPAC Update
|
Sep 29, 2025 |
|
Overcoming Colonialism in Pathogen Genomics
|
Sep 26, 2025 |
|
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 2
|
Sep 25, 2025 |
|
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 1
|
Sep 24, 2025 |
|
Outcomes Following Acute Plasma Exchange for MOGAD - Part 3
|
Sep 23, 2025 |
|
Outcomes Following Acute Plasma Exchange for MOGAD - Part 2
|
Sep 22, 2025 |
|
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 2
|
Sep 19, 2025 |
|
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 1
|
Sep 18, 2025 |
|
Outcomes Following Acute Plasma Exchange for MOGAD - Part 1
|
Sep 17, 2025 |
|
Safety and Efficacy of Satralizumab in Patients with Generalized MG
|
Sep 16, 2025 |
|
UNITE Randomized Clinical Trial
|
Sep 15, 2025 |
|
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 2
|
Sep 12, 2025 |
|
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 1
|
Sep 11, 2025 |
|
Women History Minute - Ellen Grass
|
Sep 10, 2025 |
|
Shedding a Light on Neurodiversity
|
Sep 09, 2025 |
|
Dihydroergotamine Nasal Powder
|
Sep 08, 2025 |
|
Updates on All Things Myositis – Part 2
|
Sep 05, 2025 |
|
Updates on All Things Myositis – Part 1
|
Sep 04, 2025 |
|
September 2025 President Spotlight: AAN Brain Health Summit
|
Sep 03, 2025 |
|
August 2025 Capitol Hill Report: Neurology off the Hill
|
Sep 02, 2025 |
|
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years - Part 2
|
Sep 01, 2025 |
|
GLP-1RA–Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies
|
Aug 29, 2025 |
|
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years - Part 1
|
Aug 28, 2025 |
|
Foundational Neurology Series - Part 5
|
Aug 27, 2025 |
|
Foundational Neurology Series - Part 4
|
Aug 26, 2025 |
|
Foundational Neurology Series - Part 3
|
Aug 25, 2025 |
|
FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making
|
Aug 22, 2025 |
|
Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial Fibrillation
|
Aug 21, 2025 |
|
Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
|
Aug 20, 2025 |
|
Foundational Neurology Series - Part 2
|
Aug 19, 2025 |
|
Foundational Neurology Series - Part 1
|
Aug 18, 2025 |
|
Implications for Diagnostic Criteria for Primary Lateral Sclerosis
|
Aug 15, 2025 |
|
Long-Term Fatigue Following Transient Ischemic Attack
|
Aug 14, 2025 |
|
Updates in Neuroinfectious Diseases - Part 10
|
Aug 13, 2025 |
|
Updates in Neuroinfectious Diseases - Part 9
|
Aug 12, 2025 |
|
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 2
|
Aug 11, 2025 |
|
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 1
|
Aug 08, 2025 |
|
The Effect of Epilepsy Surgery on Tonic–Clonic Seizures
|
Aug 07, 2025 |
|
Women History Minute - Tilly Edinger
|
Aug 06, 2025 |
|
August 2025 President Spotlight: Strategizing to reach the AAN’s goals
|
Aug 05, 2025 |
|
July 2025 Capitol Hill Report: Medicare Physician Fee Schedule
|
Aug 04, 2025 |
|
Medical Student Perspectives on Stigma in FND
|
Aug 01, 2025 |
|
Medical Student Perspectives on Stigma in FND
|
Aug 01, 2025 |
|
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
|
Jul 31, 2025 |
|
Updates in Neuroinfectious Diseases - Part 8
|
Jul 30, 2025 |
|
Updates in Neuroinfectious Diseases - Part 7
|
Jul 29, 2025 |
|
Updates in Neuroinfectious Diseases - Part 6
|
Jul 28, 2025 |
|
Clinical Approach to Dementia Risk in Patients with Parkinson Disease
|
Jul 25, 2025 |
|
Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
|
Jul 24, 2025 |
|
Updates in Neuroinfectious Diseases - Part 5
|
Jul 23, 2025 |
|
Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease - Part 2
|
Jul 22, 2025 |
|
July 2025 Capitol Hill Report: Reconciliation Bill
|
Jul 21, 2025 |
|
Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic
|
Jul 18, 2025 |
|
Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease - Part 1
|
Jul 17, 2025 |
|
Updates in Neuroinfectious Diseases - Part 4
|
Jul 16, 2025 |
|
Updates in Neuroinfectious Diseases - Part 3
|
Jul 15, 2025 |
|
hES Cell-Derived Dopaminergic Neurons for Parkinson Disease - Part 2
|
Jul 14, 2025 |
|
hES Cell-Derived Dopaminergic Neurons for Parkinson Disease - Part 1
|
Jul 11, 2025 |
|
Neurology Residency Training in 2022
|
Jul 10, 2025 |
|
Updates in Neuroinfectious Diseases - Part 2
|
Jul 09, 2025 |
|
Updates in Neuroinfectious Diseases - Part 1
|
Jul 08, 2025 |
|
July 2025 President Spotlight: The Role Science Plays
|
Jul 07, 2025 |
|
Prehospital Large-Vessel Occlusion Stroke Detection Scales
|
Jul 03, 2025 |
|
Women History Minute - Mary Lasker
|
Jul 02, 2025 |
|
2025 European Stroke Organization Conference Highlights - Part 3
|
Jul 01, 2025 |
|
2025 European Stroke Organization Conference Highlights - Part 2
|
Jun 30, 2025 |
|
2025 European Stroke Organization Conference Highlights - Part 1
|
Jun 27, 2025 |
|
Role of Central Sensitization Syndrome in Patients With Autonomic Symptoms
|
Jun 26, 2025 |
|
Women History Minute - Jean Holowach-Thurston
|
Jun 25, 2025 |
|
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 2
|
Jun 24, 2025 |
|
June 2025 President Spotlight: Advocacy in Neurology
|
Jun 23, 2025 |
|
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 1
|
Jun 20, 2025 |
|
Electronic Medical Record Alert to Prevent Iatrogenic Interventions in Patients With PNES
|
Jun 19, 2025 |
|
June 2025 Capitol Hill Report
|
Jun 18, 2025 |
|
Inebilizumab in Generalized Myasthenia Gravis
|
Jun 17, 2025 |
|
Optic Nerve Imaging - Part 3
|
Jun 16, 2025 |
|
Patient Perspectives on Antiseizure Medication Discontinuation
|
Jun 13, 2025 |
|
Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge
|
Jun 12, 2025 |
|
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 3
|
Jun 11, 2025 |
|
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 2
|
Jun 10, 2025 |
|
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 2
|
Jun 09, 2025 |
|
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 1
|
Jun 06, 2025 |
|
Clinical Reasoning Series: Intracerebral Hemorrhage and Tortuous Retinal Arterioles
|
Jun 05, 2025 |
|
Functional Seizures and Driving - Part 3
|
Jun 04, 2025 |
|
Functional Seizures and Driving - Part 2
|
Jun 03, 2025 |
|
Functional Seizures and Driving - Part 1
|
Jun 02, 2025 |
|
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 1
|
May 30, 2025 |
|
Clinical Criteria for LATE
|
May 29, 2025 |
|
Optic Nerve Imaging - Part 2
|
May 28, 2025 |
|
Introduction to the New AAN President, Natalia S. Rost, MD, MPH, FAAN, FAHA
|
May 27, 2025 |
|
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 2
|
May 26, 2025 |
|
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 1
|
May 23, 2025 |
|
Transforming Neurology Education: Evaluating Teaching Incentive Programs
|
May 22, 2025 |
|
Optic Nerve Imaging - Part 1
|
May 21, 2025 |
|
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2
|
May 20, 2025 |
|
AAN’s President’s Award Recipient for 2025 - Part 2
|
May 19, 2025 |
|
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1
|
May 16, 2025 |
|
AAN’s President’s Award Recipient for 2025 - Part 1
|
May 15, 2025 |
|
Progressive Multiple Sclerosis
|
May 14, 2025 |
|
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
|
May 13, 2025 |
|
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2
|
May 12, 2025 |
|
Spontaneous Intracranial Hypotension Updates
|
May 09, 2025 |
|
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1
|
May 08, 2025 |
|
Neuroimmunology Update 2025: MOGAD Treatments
|
May 07, 2025 |
|
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
|
May 06, 2025 |
|
The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
|
May 05, 2025 |
|
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
|
May 02, 2025 |
|
Women With Genetic Epilepsies
|
May 01, 2025 |
|
Neuroimmunology Update 2025: AQP4+ NMOSD Treatment Landscape
|
Apr 30, 2025 |
|
BTK Inhibitors in Multiple Sclerosis Treatment - Part 3
|
Apr 29, 2025 |
|
BTK Inhibitors in Multiple Sclerosis Treatment - Part 2
|
Apr 28, 2025 |
|
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
|
Apr 24, 2025 |
|
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
|
Apr 23, 2025 |
|
Women History Minute - Mary A. B. Brazier
|
Apr 22, 2025 |
|
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 2
|
Apr 21, 2025 |
|
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 1
|
Apr 18, 2025 |
|
Characterizing Prodrome in Migraine
|
Apr 17, 2025 |
|
Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study
|
Apr 16, 2025 |
|
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 4
|
Apr 15, 2025 |
|
Reducing Health Care Costs with Functional Seizures Clinic Referral
|
Apr 14, 2025 |
|
Neurology® Open Access - Part 2
|
Apr 11, 2025 |
|
Neurology® Open Access - Part 1
|
Apr 10, 2025 |
|
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 3
|
Apr 09, 2025 |
|
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy -Part 2
|
Apr 08, 2025 |
|
A Discussion with Dr. Gebreyohanns: 2025 Ted Burns Humanism in Neurology Award - Part 2
|
Apr 07, 2025 |
|
A Discussion with Dr. Gebreyohanns: 2025 Ted Burns Humanism in Neurology Award - Part 1
|
Apr 04, 2025 |
|
Trends and Disparities in the Utilization of Thymectomy for MG in the US
|
Apr 03, 2025 |
|
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy -Part 1
|
Apr 02, 2025 |
|
Busting Myths in Sleep, Headache and Concussion
|
Apr 01, 2025 |
|
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 4
|
Mar 31, 2025 |
|
Ten Years of Neurology® Genetics
|
Mar 28, 2025 |
|
Global Recommendations for Migraine
|
Mar 27, 2025 |
|
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 3
|
Mar 26, 2025 |
|
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 2
|
Mar 25, 2025 |
|
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 1
|
Mar 24, 2025 |
|
Association of Smoking and Young Cryptogenic Ischemic Stroke
|
Mar 21, 2025 |
|
Revolutionizing ALS Treatment: The Tofersen Breakthrough
|
Mar 20, 2025 |
|
Neurology on the Hill 2025 - Part 3
|
Mar 19, 2025 |
|
Neurology on the Hill 2025 - Part 2
|
Mar 18, 2025 |
|
Neurology on the Hill 2025 - Part 1
|
Mar 17, 2025 |
|
Frontotemporal Dementia Differential Diagnosis in Clinical Practice
|
Mar 14, 2025 |
|
The Best of Headache Medicine from 2024: A Year in Review
|
Mar 13, 2025 |
|
The Best of Headache Medicine from 2024: A Year in Review
|
Mar 13, 2025 |
|
Sleep and Brain Health
|
Mar 12, 2025 |
|
Sleep Apnea and Stroke Risk
|
Mar 11, 2025 |
|
Association of Migraine Treatments with Reduced Ischemic Stroke Risk
|
Mar 10, 2025 |
|
Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS
|
Mar 07, 2025 |
|
Overview from the 2025 International Stroke Conference - Part 2
|
Mar 06, 2025 |
|
Overview from the 2025 International Stroke Conference - Part 1
|
Mar 05, 2025 |
|
Acquired Dystonia
|
Mar 04, 2025 |
|
Orthostatic Tremor
|
Mar 03, 2025 |
|
Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 2
|
Feb 28, 2025 |
|
Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 1
|
Feb 27, 2025 |
|
Vascular Risk Factor Burden Among Young Adults with Ischemic Stroke
|
Feb 26, 2025 |
|
First Drug Approved in New Class of Non-Opioid Pain Medicines
|
Feb 25, 2025 |
|
Lab Minute - Antiphospholipid Syndrome
|
Feb 24, 2025 |
|
Epidural Steroids for Cervical and Lumbar Radicular Pain and Spinal Stenosis
|
Feb 21, 2025 |
|
The Neurologist's Role in Promoting Brain Health
|
Feb 20, 2025 |
|
Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis, Testing, and Management in Children With Headache
|
Feb 19, 2025 |
|
Consensus Recommendations for the Management of Neurosarcoidosis - Part 2
|
Feb 18, 2025 |
|
Women History Minute - Audrey Shields Penn
|
Feb 17, 2025 |
|
Consensus Recommendations for the Management of Neurosarcoidosis - Part 1
|
Feb 14, 2025 |
|
Effects of Intensive Lifestyle Changes on the Progression of MCI or Early Dementia
|
Feb 13, 2025 |
|
Women History Minute - Anne Beaumanoir
|
Feb 12, 2025 |
|
New Restless Leg Syndrome Guidance - Part 2
|
Feb 11, 2025 |
|
Burnout in Practicing Neurologists - Part 4
|
Feb 10, 2025 |
|
New Restless Leg Syndrome Guidance - Part 1
|
Feb 07, 2025 |
|
Dementia Prevention, Intervention, and Care
|
Feb 06, 2025 |
|
Burnout in Practicing Neurologists - Part 3
|
Feb 05, 2025 |
|
Burnout in Practicing Neurologists - Part 2
|
Feb 04, 2025 |
|
Burnout in Practicing Neurologists - Part 1
|
Feb 03, 2025 |
|
The Brain’s Action-Mode Network
|
Jan 31, 2025 |
|
Ten Years of Neurology® Neuroimmunology & Neuroinflammation Decade in Review - Part 2
|
Jan 30, 2025 |
|
Ten Years of Neurology® Neuroimmunology & Neuroinflammation Decade in Review - Part 1
|
Jan 29, 2025 |
|
Autoimmune Epilepsy
|
Jan 28, 2025 |
|
Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine
|
Jan 27, 2025 |
|
Superhuman Performance of a LLM on the Reasoning Tasks of a Physician
|
Jan 24, 2025 |
|
Attitudes and Perceptions on Palliative Care
|
Jan 23, 2025 |
|
Enhancing Adherence to PAP Therapy
|
Jan 22, 2025 |
|
Understanding Circadian Rhythm
|
Jan 21, 2025 |
|
Women History Minute - Mary Whiton Calkins
|
Jan 20, 2025 |
|
CSF Correction Factors for Traumatic Lumbar Puncture in Adults
|
Jan 17, 2025 |
|
Changes in Cerebral and Hypothalamic Structure With Sleep Dysfunction in Patients With Genetic FTD
|
Jan 16, 2025 |
|
Women History Minute - Maria Mikhaĭlovna Manàsseina
|
Jan 15, 2025 |
|
Women History Minute - Ana Judith Roman Garcia
|
Jan 14, 2025 |
|
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma - Part 2
|
Jan 13, 2025 |
|
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma - Part 1
|
Jan 10, 2025 |
|
Using Design Thinking to Understand the Reason for Headache Referrals
|
Jan 09, 2025 |
|
Lab Minutes - Paraneoplastic Lab
|
Jan 08, 2025 |
|
Lab Minutes - Myasthenia Gravis Lab
|
Jan 07, 2025 |
|
Lab Minutes - IgG vs. IgM
|
Jan 06, 2025 |
|
Clinical Implementation of fMRI and EEG to Detect CMD
|
Jan 02, 2025 |
|
2024 Guideline for the Primary Prevention of Stroke - Part 5
|
Jan 01, 2025 |
|
2024 Guideline for the Primary Prevention of Stroke - Part 4
|
Dec 31, 2024 |
|
Empowering Health Care Providers
|
Dec 30, 2024 |
|
2024 Guideline for the Primary Prevention of Stroke - Part 3
|
Dec 30, 2024 |
|
Disparities in Utilization of Outpatient Telemedicine for Neurologic Care
|
Dec 27, 2024 |
|
2024 Guideline for the Primary Prevention of Stroke - Part 2
|
Dec 26, 2024 |
|
2024 Guideline for the Primary Prevention of Stroke - Part 1
|
Dec 25, 2024 |
|
Artificial Intelligence in Residency Recruitment - Part 2
|
Dec 24, 2024 |
|
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 2
|
Dec 23, 2024 |
|
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 1
|
Dec 20, 2024 |
|
Artificial Intelligence in Residency Recruitment - Part 1
|
Dec 19, 2024 |
|
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 3
|
Dec 18, 2024 |
|
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 2
|
Dec 17, 2024 |
|
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 1
|
Dec 16, 2024 |
|
Central Mechanisms of Cough and Their Neurologic Implications
|
Dec 13, 2024 |
|
Medical Forecasting - Part 2
|
Dec 12, 2024 |
|
Medical Forecasting - Part 1
|
Dec 11, 2024 |
|
Understanding Amyloidosis
|
Dec 10, 2024 |
|
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 2
|
Dec 09, 2024 |
|
Distinguishing Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer Disease
|
Dec 06, 2024 |
|
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 1
|
Dec 05, 2024 |
|
CMS Releases Final 2025 Physician Fee Schedule - Part 3
|
Dec 04, 2024 |
|
CMS Releases Final 2025 Physician Fee Schedule - Part 2
|
Dec 03, 2024 |
|
CMS Releases Final 2025 Physician Fee Schedule - Part 1
|
Dec 02, 2024 |
|
Understanding Acute Symptomatic Seizures
|
Nov 29, 2024 |
|
Features of Educational Social Media Posts - Part 2
|
Nov 28, 2024 |
|
Features of Educational Social Media Posts - Part 1
|
Nov 27, 2024 |
|
Hereditary Ataxia SCA27B
|
Nov 26, 2024 |
|
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
|
Nov 25, 2024 |
|
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
|
Nov 25, 2024 |
|
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 1
|
Nov 22, 2024 |
|
Myelitis Associated With Rheumatologic Disease - Part 2
|
Nov 21, 2024 |
|
Myelitis Associated With Rheumatologic Disease - Part 1
|
Nov 20, 2024 |
|
Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?
|
Nov 19, 2024 |
|
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3
|
Nov 18, 2024 |
|
The Placebo Effect
|
Nov 15, 2024 |
|
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2
|
Nov 14, 2024 |
|
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1
|
Nov 13, 2024 |
|
Lab Minute - Vitamin D
|
Nov 12, 2024 |
|
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading
|
Nov 11, 2024 |
|
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
|
Nov 08, 2024 |
|
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
|
Nov 07, 2024 |
|
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
|
Nov 06, 2024 |
|
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
|
Nov 05, 2024 |
|
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3
|
Nov 04, 2024 |
|
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
|
Nov 01, 2024 |
|
Interventions for the Acute Management of Migraine Episodes in Adults - Part 2
|
Oct 31, 2024 |
|
Interventions for the Acute Management of Migraine Episodes in Adults - Part 1
|
Oct 30, 2024 |
|
Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves
|
Oct 29, 2024 |
|
Women History Minute - The Women of the Cajal School
|
Oct 28, 2024 |
|
Revised Criteria for Diagnosis and Staging of Alzheimer Disease
|
Oct 25, 2024 |
|
End-of-Life Health Care Service Use and Cost
|
Oct 24, 2024 |
|
Women History Minute - Cecile Vogt
|
Oct 23, 2024 |
|
Neurology on the Hill
|
Oct 22, 2024 |
|
A Comparison of Side Effects for Four First-line Antiseizure Medications
|
Oct 21, 2024 |
|
Epilepsy in Patients With Primary CNS Lymphoma
|
Oct 18, 2024 |
|
The Rise of the Science Sleuths - Part 3
|
Oct 17, 2024 |
|
Lab Minute - B Vitamins
|
Oct 16, 2024 |
|
Lab Minute - ACE levels
|
Oct 15, 2024 |
|
How to Respond to a Request for Hastened Death from a Person Living with Neurologic Illness
|
Oct 14, 2024 |
|
The Rise of the Science Sleuths - Part 2
|
Oct 11, 2024 |
|
The Rise of the Science Sleuths - Part 1
|
Oct 10, 2024 |
|
Lab Minute - Thyroid Antibodies
|
Oct 09, 2024 |
|
Lab Minute - IgG4
|
Oct 08, 2024 |
|
Deep Brain Stimulation of Symptom-Specific Networks in Parkinson Disease - Part 2
|
Oct 07, 2024 |
|
Global Burden of Neurologic Conditions
|
Oct 04, 2024 |
|
Deep Brain Stimulation of Symptom-Specific Networks in Parkinson Disease - Part 1
|
Oct 03, 2024 |
|
Lab Minute - Iron
|
Oct 02, 2024 |
|
What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy
|
Oct 01, 2024 |
|
The Topic of Neurological Care for Transgender Patients - Part 3
|
Sep 30, 2024 |
|
Relapsing-Remitting Immunotherapy Responsive SFN
|
Sep 27, 2024 |
|
Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society
|
Sep 26, 2024 |
|
The Topic of Neurological Care for Transgender Patients - Part 2
|
Sep 25, 2024 |
|
The Topic of Neurological Care for Transgender Patients - Part 1
|
Sep 24, 2024 |
|
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 2
|
Sep 23, 2024 |
|
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 1
|
Sep 20, 2024 |
|
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
|
Sep 19, 2024 |
|
Improving Clinical Documentation Efficiency with AI
|
Sep 18, 2024 |
|
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2
|
Sep 17, 2024 |
|
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene
|
Sep 16, 2024 |
|
Monoclonal Antibody to PACAP for Migraine Prevention - Part 1
|
Sep 13, 2024 |
|
Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH
|
Sep 12, 2024 |
|
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
|
Sep 11, 2024 |
|
Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses
|
Sep 10, 2024 |
|
Spinal Muscular Atrophy Update in Best Practices - Part 3
|
Sep 09, 2024 |
|
Specialist Physiotherapy for Functional Motor Disorder
|
Sep 06, 2024 |
|
Spinal Muscular Atrophy Update in Best Practices - Part 2
|
Sep 05, 2024 |
|
Spinal Muscular Atrophy Update in Best Practice - Part 1
|
Sep 04, 2024 |
|
Blood Biomarkers to Detect Alzheimer Disease - Part 2
|
Sep 03, 2024 |
|
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2
|
Sep 02, 2024 |
|
Blood Biomarkers to Detect Alzheimer Disease - Part 1
|
Aug 30, 2024 |
|
Blood Biomarkers to Detect Alzheimer Disease - Part 1
|
Aug 30, 2024 |
|
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1
|
Aug 29, 2024 |
|
New Treatment Option for Parkinson Disease
|
Aug 28, 2024 |
|
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease
|
Aug 27, 2024 |
|
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse
|
Aug 26, 2024 |
|
Neuropsychological Profiles of Deployment-Related mTBI
|
Aug 23, 2024 |
|
Long-Term Dementia Risk in Parkinson Disease - Part 1
|
Aug 22, 2024 |
|
Interpreting DAT Imaging Results in the Clinical Context - Part 2
|
Aug 21, 2024 |
|
Understanding Long COVID - Part 2
|
Aug 20, 2024 |
|
Understanding Long COVID - Part 1
|
Aug 19, 2024 |
|
Interpreting DAT Imaging Results in the Clinical Context
|
Aug 16, 2024 |
|
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1
|
Aug 15, 2024 |
|
AHS Position Statement
|
Aug 14, 2024 |
|
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core - Part 2
|
Aug 13, 2024 |
|
Transient Smartphone Blindness
|
Aug 12, 2024 |
|
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core
|
Aug 09, 2024 |
|
The Ethical Landscape of Prodromal Parkinson Disease
|
Aug 08, 2024 |
|
Movement Disorders Emergencies - Part 3
|
Aug 07, 2024 |
|
Movement Disorders Emergencies - Part 2
|
Aug 06, 2024 |
|
Movement Disorders Emergencies - Part 1
|
Aug 05, 2024 |
|
Association of Prenatal Exposure to Antiseizure Medications
|
Aug 02, 2024 |
|
Tapping the Brakes on New Parkinson Disease Biological Staging
|
Aug 01, 2024 |
|
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2
|
Jul 31, 2024 |
|
Large Language Models for Quality and Efficiency of Neurologic Care - Part 2
|
Jul 30, 2024 |
|
Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency - Part 2
|
Jul 29, 2024 |
|
Large Language Models for Quality and Efficiency of Neurologic Care - Part 1
|
Jul 26, 2024 |
|
Transcobalamin receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency
|
Jul 25, 2024 |
|
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 1
|
Jul 24, 2024 |
|
Women History Minute - Marian Molly Putnam
|
Jul 23, 2024 |
|
Understanding Apathy in Parkinson Disease - Part 2
|
Jul 22, 2024 |
|
Understanding Apathy in Parkinson Disease - Part 1
|
Jul 19, 2024 |
|
Paraneoplastic CAMKV Autoimmune Encephalitis
|
Jul 18, 2024 |
|
Women History Minute - Mary Putnam Jacobi
|
Jul 17, 2024 |
|
An Angiotensin Receptor Blocker for Hypertension Is Associated With a Reduced Risk for Epilepsy
|
Jul 16, 2024 |
|
Systematic Review of Individuals with Seropositive MOGAD
|
Jul 15, 2024 |
|
Epidural Patching Outcomes and Predictors of Benefit in Patients With Suspected CSF Leak
|
Jul 12, 2024 |
|
Physician as Patient Series - Multiple Sclerosis
|
Jul 11, 2024 |
|
Physician as Patient Series - Multiple Sclerosis
|
Jul 11, 2024 |
|
Women History Minute - Ema Gibbs
|
Jul 10, 2024 |
|
Women History Minute - Marie Joubert
|
Jul 09, 2024 |
|
Women History Minute - Mary Spink and Alice Bennett
|
Jul 08, 2024 |
|
Talk with AAN President
|
Jul 05, 2024 |
|
Highlights of the 2024 European Stroke Organization Conference
|
Jul 04, 2024 |
|
Association between Radiographic Features of Hypertrophic Pachymeningitis and its Underlying Diagnoses
|
Jul 03, 2024 |
|
Prospective Study Presents Longitudinal Trajectory of Cognitive Impairment in Patients With Essential Tremor
|
Jul 02, 2024 |
|
Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors
|
Jul 01, 2024 |
|
Refractory Headache Part 3
|
Jun 28, 2024 |
|
AAN Brain Health Initiative
|
Jun 27, 2024 |
|
CSF Metagenomics and Host Transcriptomics of Cryptogenic New-onset Refractory Status Epilepticus
|
Jun 26, 2024 |
|
Withdrawing Life Support for Patients with Severe Brain Injury
|
Jun 25, 2024 |
|
Refractory Headache Series Part 2
|
Jun 24, 2024 |
|
Refractory Headache Series Part 1
|
Jun 21, 2024 |
|
Mortality in a Danish NMO Cohort
|
Jun 20, 2024 |
|
Neuromodulation for Primary Headache - Part 6
|
Jun 19, 2024 |
|
Migraine and Headache Awareness Month
|
Jun 18, 2024 |
|
Women History Minute - Eliska Klimkova-Deutschova
|
Jun 17, 2024 |
|
Glucose Control and ICH Risk
|
Jun 14, 2024 |
|
Cortical Morphology in Migraine
|
Jun 13, 2024 |
|
Women History Minute - Isabelle Rapin
|
Jun 12, 2024 |
|
Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Part 2
|
Jun 11, 2024 |
|
Women History Minute - Mary Anne Guggenheim
|
Jun 10, 2024 |
|
Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Part 1
|
Jun 07, 2024 |
|
Comparing IV Thrombolysis to Endovascular Therapy in Basilar Occlusion
|
Jun 06, 2024 |
|
Women History Minute - Louise Eisenhardt
|
Jun 05, 2024 |
|
Neuromodulation for Primary Headache - Part 5
|
Jun 04, 2024 |
|
Physicians as Patients Series - Inclusivity of Physicians with Disabilities - Part 2
|
Jun 03, 2024 |
|
Seizure Recurrence in Generalized Epilepsy After Switching Away From Valproate
|
May 31, 2024 |
|
Physicians as Patients Series - Inclusivity of physicians with disabilities - Part 1
|
May 30, 2024 |
|
Updates on the Impact of Sleep Apnea on Cognition and Dementia Risk
|
May 29, 2024 |
|
Study Identifies Disparities in Access to Neurodiagnostic Studies for Drug-Resistant Epilepsy
|
May 28, 2024 |
|
Randomized Trial of Cannabis Extract in Parkinson- Part 2
|
May 27, 2024 |
|
Randomized Trial of Cannabis Extract in Parkinson- Part 1
|
May 24, 2024 |
|
Game Based Learning in Neuroscience
|
May 23, 2024 |
|
Neuromodulation for Primary Headache - Part 4
|
May 22, 2024 |
|
Neuromodulation for Primary Headache - Part 3
|
May 21, 2024 |
|
AAN Summer Conference
|
May 20, 2024 |
|
Teratogenesis and Neurodevelopment on Antiseizure Medication: A Practice Guideline
|
May 17, 2024 |
|
Neurologic Diagnoses after COVID-19 or Influenza Hospitalization
|
May 16, 2024 |
|
These AI Hacks Could Alleviate Administrative Burden
|
May 15, 2024 |
|
Psychogenic Non-Epileptic Seizures - Part 3
|
May 14, 2024 |
|
Neuromodulation for Primary Headache - Part 2
|
May 13, 2024 |
|
Long-Term Follow-Up of the LEAP Study
|
May 10, 2024 |
|
Herpes Simplex Virus Encephalitis
|
May 09, 2024 |
|
Neuromodulation for Primary Headache - Part 1
|
May 08, 2024 |
|
Psychogenic Non-Epileptic Seizures - Part 2
|
May 07, 2024 |
|
Idiopathic Generalized Epilepsy - Part 5
|
May 06, 2024 |
|
Unrecognized Focal Non-Motor Seizures in Adolescents
|
May 03, 2024 |
|
sNfL and Radiologic Disease Activity in Patients With MS - Part 2
|
May 02, 2024 |
|
sNfL and Radiologic Disease Activity in Patients With MS - Part 1
|
May 01, 2024 |
|
Psychogenic Non-Epileptic Seizures - Part 1
|
Apr 30, 2024 |
|
Idiopathic Generalized Epilepsy - Part 4
|
Apr 29, 2024 |
|
Clinical Characteristics and Long-Term Outcomes of Late-Onset MS
|
Apr 26, 2024 |
|
Skin Biopsy Detection of Phosphorylated α-Synuclein
|
Apr 25, 2024 |
|
Idiopathic Generalized Epilepsy - Part 3
|
Apr 24, 2024 |
|
Pathogen Detection and Associated Patient Characteristics from Clinical Metagenomic Next-generation Sequencing Testing for Neurological Infections
|
Apr 23, 2024 |
|
Clinical Phenomenology Distinguishing Functional Tic-Like Behaviors from Primary Tics in Young People
|
Apr 22, 2024 |
|
Physicians as Patients Series - Arteriovenous Malformation Part 2
|
Apr 19, 2024 |
|
Idiopathic Generalized Epilepsy - Part 2
|
Apr 18, 2024 |
|
Robert Frost’s Inaugural Woes: A Differential Diagnosis for his Acute Vision Loss
|
Apr 17, 2024 |
|
Physicians as Patients Series - Arteriovenous Malformation Part 1
|
Apr 16, 2024 |
|
Evaluation of the Diagnostic Utility of Caveolae-associated Protein 4 (cavin-4) Epitope-based ELISA in Identification of Immune Mediated Rippling Muscle Disease
|
Apr 15, 2024 |
|
Educating Child Neurology Residents About PNES
|
Apr 12, 2024 |
|
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
|
Apr 11, 2024 |
|
Defining the CSF Cytokine and Chemokine Signature of Neurosarcoidosis
|
Apr 10, 2024 |
|
A Discussion with Dr. Avindra Nath: Ted Burns Humanism Award Winner - Part 2
|
Apr 09, 2024 |
|
Randomized Controlled Trial of iSTAND
|
Apr 08, 2024 |
|
Impact of Immune Checkpoint Inhibitors
|
Apr 05, 2024 |
|
Space Headaches Experienced by Astronauts
|
Apr 04, 2024 |
|
IGE Introduction - Part 1
|
Apr 03, 2024 |
|
Disability in NMOSD vs MOGAD
|
Apr 02, 2024 |
|
Updates on the NAEC Guidelines
|
Apr 01, 2024 |
|
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
|
Mar 29, 2024 |
|
A Discussion with Dr. Avindra Nath: Ted Burns Humanism Award Winner - Part 1
|
Mar 28, 2024 |
|
The Role EEG Plays in the Clinical Practice
|
Mar 27, 2024 |
|
Early Identification of Candidates for Epilepsy Surgery
|
Mar 26, 2024 |
|
Brain Iron Accumulation in Participants with Acute Post-traumatic Headache
|
Mar 25, 2024 |
|
Effectiveness of Seizure Dogs
|
Mar 22, 2024 |
|
Neurodevelopmental and Functional Outcomes Following In Utero Exposure to Anti-Seizure Medication
|
Mar 21, 2024 |
|
Disclosing the Risk Associated with Isolated REM Behavior Disorder
|
Mar 20, 2024 |
|
Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia
|
Mar 19, 2024 |
|
Lecanemab in Alzheimer Disease
|
Mar 18, 2024 |
|
Clinical Assessment of Anti-IgLON5 Disease
|
Mar 15, 2024 |
|
Disparities in Genetic Testing for Neurologic Disorders
|
Mar 14, 2024 |
|
Seizure Dogs Reduce Frequency of Seizures, but Discontinuations are Common
|
Mar 13, 2024 |
|
Distinguish Parkinson Disease from Functional Parkinsonism
|
Mar 12, 2024 |
|
Support Medical Research and Funding
|
Mar 11, 2024 |
|
The Perils and Pitfalls of Global Engagement
|
Mar 08, 2024 |
|
National Association of Epilepsy Centers Updated Guidelines
|
Mar 07, 2024 |
|
Medicare Physician Reimbursement
|
Mar 06, 2024 |
|
Step Therapy Reform and the Safe Step Act
|
Mar 05, 2024 |
|
What is Neurology on the Hill?
|
Mar 04, 2024 |
|
Migraine-Related Stigma - Part 2
|
Mar 01, 2024 |
|
Migraine-Related Stigma - Part 1
|
Feb 29, 2024 |
|
Multiple Sclerosis and Family Planning
|
Feb 28, 2024 |
|
Multiple Sclerosis and Family Planning
|
Feb 28, 2024 |
|
Women History Minute - Mary Broadfoot Walker
|
Feb 27, 2024 |
|
5-Year Neurology Minute Anniversary
|
Feb 26, 2024 |
|
Serine-129 Phosphorylation of α-Synuclein
|
Feb 23, 2024 |
|
Neuropathologic Burden and Dementia in Nonagenarians and Centenarians
|
Feb 22, 2024 |
|
American Brain Foundation - Robert C. Griggs, MD, FAAN Fund
|
Feb 21, 2024 |
|
Women History Minute - Kinuko Suzuki
|
Feb 20, 2024 |
|
Women History Minute - Florence Rena Sabin
|
Feb 19, 2024 |
|
Idiopathic Hypersomnia in the Wisconsin Sleep Cohort Study
|
Feb 16, 2024 |
|
Neurologic Clinical Features of Patients With CTLA4 Deficiency
|
Feb 15, 2024 |
|
Lab Minute - CMP
|
Feb 14, 2024 |
|
Lab Minute - ANCA
|
Feb 13, 2024 |
|
Neurology Lab Minute - ANA
|
Feb 12, 2024 |
|
UnitedHealth Faces Class Action Lawsuit Over Algorithmic Care Denials
|
Feb 09, 2024 |
|
Blepharoclonus in Parkinsonism - Part 2
|
Feb 08, 2024 |
|
Blepharoclonus in Parkinsonism - Part 1
|
Feb 07, 2024 |
|
Delayed Post-Hypoxic Leukoencephalopathy
|
Feb 06, 2024 |
|
Women History Minute - Sarah McNutt
|
Feb 05, 2024 |
|
Vascular Risk Factors and Biomarker Association With White Matter Hyperintensities in American Football Players
|
Feb 02, 2024 |
|
Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Cardiovascular and Cerebrovascular Risk
|
Feb 01, 2024 |
|
History of Neurology - Augusta Dejerine-Klumpke
|
Jan 31, 2024 |
|
Transforming Neurology Care
|
Jan 30, 2024 |
|
A Comprehensive, Updated Review for the Clinician on Zonisamide
|
Jan 29, 2024 |
|
Solutions to Reduce the Global Burden of Stroke
|
Jan 26, 2024 |
|
Reviewing Psychogenic Non-Epileptic Events
|
Jan 25, 2024 |
|
Guidelines for Acute Stroke
|
Jan 24, 2024 |
|
Advanced MRI Biomarkers Lead to More Accurate Diagnosis in Multiple Sclerosis
|
Jan 23, 2024 |
|
Treating Migraines Before They Start - PRODROME Trial
|
Jan 22, 2024 |
|
A Secret War
|
Jan 19, 2024 |
|
Performance of a [18F]Flortaucipir PET Visual Read Method
|
Jan 18, 2024 |
|
Visual Disturbances in Optic Chiasm Lesions - Part 3
|
Jan 17, 2024 |
|
Visual Disturbances in Optic Chiasm Lesions - Part 2
|
Jan 16, 2024 |
|
Visual Disturbances in Optic Chiasm Lesions - Part 1
|
Jan 15, 2024 |
|
COVID-19 Vaccination and Guillain-Barré Syndrome
|
Jan 12, 2024 |
|
Hospitalizations and Mortality From Myasthenia Gravis
|
Jan 11, 2024 |
|
Work, Parenting, and Well-being - Part 2
|
Jan 10, 2024 |
|
Myoclonus-Dystonia
|
Jan 09, 2024 |
|
Headache Pearls
|
Jan 08, 2024 |
|
Reforming Pharmacy Benefit Managers — A Review of Bipartisan Legislation
|
Jan 05, 2024 |
|
Guillain-Barré Syndrome and COVID-19 Infection and Vaccination
|
Jan 04, 2024 |
|
Anti-Seizure Medications: Part 3
|
Jan 03, 2024 |
|
Anti-Seizure Medications: Part 2
|
Jan 02, 2024 |
|
Anti-Seizure Medications: Part 1
|
Jan 01, 2024 |
|
Work, Parenting, and Well-being - Part 1
|
Dec 29, 2023 |
|
Physician as Patient
|
Dec 28, 2023 |
|
Neonatal Seizure Treatment
|
Dec 27, 2023 |
|
Advocacy Update - Part 2
|
Dec 26, 2023 |
|
Advocacy Update - Part 1
|
Dec 25, 2023 |
|
IHC Among Blood Donors and Their Transfusion Recipients
|
Dec 22, 2023 |
|
Frequency of OH in Isolated REM Sleep Behavior Disorder
|
Dec 21, 2023 |
|
Incorporating Genetic Testing Into the Care of Patients with ALS/FTD
|
Dec 20, 2023 |
|
History of Neurology: Dr. Rita Levi Montalcini
|
Dec 19, 2023 |
|
History of Neurology: Dr. Dorothy Russell
|
Dec 18, 2023 |
|
Neuroimaging Findings Across Substance Use Disorders - Part 2
|
Dec 15, 2023 |
|
Neuroimaging Findings Across Substance Use Disorders - Part 1
|
Dec 14, 2023 |
|
Global Initiatives on NMOSD and MOGAD
|
Dec 13, 2023 |
|
Prehospital Detection of Large Vessel Occlusion Stroke With EEG - Part 2
|
Dec 12, 2023 |
|
Update on Mechanisms of Migraine - Part 2
|
Dec 11, 2023 |
|
Incorporating Genetic Testing Into the Care of Patients with ALS/FTD
|
Dec 08, 2023 |
|
Prehospital Detection of Large Vessel Occlusion Stroke With EEG
|
Dec 07, 2023 |
|
Back to the Basics in Predictive Modeling—Predicting Surgical Success - Part 3
|
Dec 06, 2023 |
|
Back to the Basics in Predictive Modeling—Predicting Surgical Success - Part 2
|
Dec 05, 2023 |
|
Back to the Basics in Predictive Modeling—Predicting Surgical Success - Part 1
|
Dec 04, 2023 |
|
CMS Final Rule - Part 3
|
Nov 29, 2023 |
|
CMS Final Rule - Part 2
|
Nov 28, 2023 |
|
CMS Final Rule - Part 1
|
Nov 27, 2023 |
|
Update on Mechanisms of Migraine
|
Nov 24, 2023 |
|
Highlights from the 2023 World Stroke Congress - Part 2
|
Nov 23, 2023 |
|
Highlights from the 2023 World Stroke Congress - Part 1
|
Nov 22, 2023 |
|
Daily Persistent Headaches
|
Nov 21, 2023 |
|
IIH and Low CSF Issues - Part 2
|
Nov 20, 2023 |
|
IIH and Low CSF Issues - Part 1
|
Nov 17, 2023 |
|
Brain Tumor Programs in Asia and Africa
|
Nov 16, 2023 |
|
Neurology Lab Tests - Part 3
|
Nov 15, 2023 |
|
Neurology Lab Tests - Part 2
|
Nov 14, 2023 |
|
Neurology Lab Tests - Part 1
|
Nov 13, 2023 |
|
Commonly Missed and Less Known Headache Disorders
|
Nov 10, 2023 |
|
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline
|
Nov 09, 2023 |
|
Evaluation of Newly Diagnosed Papilledema
|
Nov 08, 2023 |
|
Dopamine Transporter (DAT) Imaging
|
Nov 07, 2023 |
|
Spiky Minute: Indications for EMU monitoring
|
Nov 06, 2023 |
|
Recap from the International Headache Conference
|
Nov 03, 2023 |
|
Diffusion-Restricted Lesions of the Splenium
|
Nov 02, 2023 |
|
Sleep Patterns and the Risk of Acute Stroke
|
Nov 01, 2023 |
|
Early Treatment of Multiple Sclerosis
|
Oct 31, 2023 |
|
Chronic Traumatic Encephalopathy Found Post-mortem in Young Athletes Who Played Contact Sports
|
Oct 30, 2023 |
|
The Brain Health Imperative in the 21st Century
|
Oct 27, 2023 |
|
Lifetime Exposure to Female Hormones With Cerebral Small Vessel Disease
|
Oct 26, 2023 |
|
Chronic Immune-Mediated Demyelinating Neuropathies - Part 3
|
Oct 25, 2023 |
|
Chronic Immune-Mediated Demyelinating Neuropathies - Part 2
|
Oct 24, 2023 |
|
Chronic Immune-Mediated Demyelinating Neuropathies - Part 1
|
Oct 23, 2023 |
|
MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients
|
Oct 20, 2023 |
|
Blood Test for Alzheimer's Disease
|
Oct 19, 2023 |
|
Improving Early Recognition of Treatment-Responsive Causes of RPD
|
Oct 18, 2023 |
|
Eye Movements to Diagnose Movement Disorders - Part 5
|
Oct 17, 2023 |
|
Eye Movements to Diagnose Movement Disorders - Part 4
|
Oct 16, 2023 |
|
Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
|
Oct 13, 2023 |
|
Sleep Patterns and the Risk of Acute Stroke
|
Oct 12, 2023 |
|
Eye Movements to Diagnose Movement Disorders - Part 3
|
Oct 11, 2023 |
|
Eye Movements to Diagnose Movement Disorders - Part 2
|
Oct 10, 2023 |
|
Eye Movements to Diagnose Movement Disorders - Part 1
|
Oct 09, 2023 |
|
Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence
|
Oct 06, 2023 |
|
Associations Between Traumatic Brain Injury and Cognitive Decline Among Older Veteran Men
|
Oct 05, 2023 |
|
Antibody-Associated Autoimmune Encephalitis
|
Oct 04, 2023 |
|
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
|
Oct 03, 2023 |
|
Diagnosis and Treatment of Trigeminal Neuralgia
|
Oct 02, 2023 |
|
Patient Travel Distance to Neurologist Visits
|
Sep 29, 2023 |
|
Prognostic Language in Critical Neurologic Illness
|
Sep 28, 2023 |
|
Depression in Multiple Sclerosis
|
Sep 27, 2023 |
|
Seizures from Sleep Are Highly Likely to Recur, New Study Shows
|
Sep 26, 2023 |
|
More Than a Wink -Identifying and Localizing Horner Syndrome
|
Sep 25, 2023 |
|
Progressive Multifocal Leukoencephalopathy
|
Sep 22, 2023 |
|
NINDS Health Equity Efforts
|
Sep 21, 2023 |
|
Sleep Disorders in Patients with Neurologic Disease - Part 3
|
Sep 20, 2023 |
|
Sleep Disorders in Patients with Neurologic Disease - Part 2
|
Sep 19, 2023 |
|
Sleep Disorders in Patients with Neurologic Disease - Part 1
|
Sep 18, 2023 |
|
Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults
|
Sep 14, 2023 |
|
Association Between Peer Victimization, Gender Diversity, Mental Health, and Recurrent Headaches in Adolescents - Part 3
|
Sep 13, 2023 |
|
Association Between Peer Victimization, Gender Diversity, Mental Health, and Recurrent Headaches in Adolescents - Part 2
|
Sep 12, 2023 |
|
Association Between Peer Victimization, Gender Diversity, Mental Health, and Recurrent Headaches in Adolescents - Part 1
|
Sep 11, 2023 |
|
Variation in Endpoints for FDA Approved Migraine Therapies
|
Sep 07, 2023 |
|
Obstructive Sleep Apnea - Part 3
|
Sep 06, 2023 |
|
Obstructive Sleep Apnea - Part 2
|
Sep 05, 2023 |
|
Obstructive Sleep Apnea - Part 1
|
Sep 04, 2023 |
|
An Updated Round Table Discussion on FND: How and Why Does FND Occur?
|
Aug 31, 2023 |
|
Low-Dose Aspirin and the Risk of Stroke
|
Aug 28, 2023 |
|
Spontaneous Intracranial Hypotension
|
Aug 25, 2023 |
|
Using Brain Network Mapping in Lesion-Related Epilepsy
|
Aug 25, 2023 |
|
Sleep Medicine Case Discussion
|
Aug 23, 2023 |
|
Lecanemab Approval
|
Aug 21, 2023 |
|
A Neurologist’s Experience as a Patient with ALS
|
Aug 18, 2023 |
|
Autoimmune Encephalitis Series: Expanding the Differential
|
Aug 17, 2023 |
|
Using Handwriting and Drawing to Evaluate Movement Disorders: Part 3
|
Aug 16, 2023 |
|
Using Handwriting and Drawing to Evaluate Movement Disorders: Part 2
|
Aug 16, 2023 |
|
Using Handwriting and Drawing to Evaluate Movement Disorders: Part 1
|
Aug 14, 2023 |
|
Autoimmune Encephalitis Series: A Rationale Approach to Diagnostics and Interpretation
|
Aug 11, 2023 |
|
Autoimmune Encephalitis Series: Advancing the Science
|
Aug 10, 2023 |
|
Carotid Web
|
Aug 09, 2023 |
|
Sports, Exercise, and Seizure Control - Part 2
|
Aug 08, 2023 |
|
Sports, Exercise, and Seizure Control - Part 1
|
Aug 07, 2023 |
|
A Round Table Update Discussion on FND: Diagnosis of FND and New Phenotypes
|
Aug 04, 2023 |
|
AAN President Elect Rost to Testify on New Alzheimer’s Treatments
|
Aug 03, 2023 |
|
When Myoclonus is Reversible
|
Aug 02, 2023 |
|
2024 Medicare Physician Fee Schedule Proposed Rule
|
Aug 01, 2023 |
|
Pediatric Epilepsy Surgery
|
Jul 31, 2023 |
|
Elamipretide for Mytochondrial Myopathy
|
Jul 28, 2023 |
|
Sarepta Announces FDA Approval of ELEVIDYS
|
Jul 27, 2023 |
|
Anti-Seizure Medication
|
Jul 26, 2023 |
|
Cognitive Decline Following Heart Attack
|
Jul 25, 2023 |
|
Traumatic Brain Injury in Children
|
Jul 24, 2023 |
|
New Treatment for IDH Mutant Gliomas
|
Jul 21, 2023 |
|
Patient-Assistance Programs, Kickbacks, and the Courts
|
Jul 20, 2023 |
|
Neurologic Complications of Cardiac and Pulmonary Disease: Part 3
|
Jul 19, 2023 |
|
Neurologic Complications of Cardiac and Pulmonary Disease: Part 2
|
Jul 18, 2023 |
|
Neurologic Complications of Cardiac and Pulmonary Disease: Part 1
|
Jul 17, 2023 |
|
Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke
|
Jul 14, 2023 |
|
Clinico-radiologic and Pathological Evaluation of Corticobasal Syndrome
|
Jul 14, 2023 |
|
Interstate Medical Licensure Compact
|
Jul 12, 2023 |
|
Traumatic Encephalopathy Syndrome
|
Jul 11, 2023 |
|
Migraine and Sleep
|
Jul 10, 2023 |
|
Simulation-Based Planning of ALS Trials
|
Jul 07, 2023 |
|
CSF Findings Across GBS
|
Jul 06, 2023 |
|
Substance Use and the Nervous System - Part 3
|
Jul 05, 2023 |
|
Substance Use and the Nervous System - Part 2
|
Jul 04, 2023 |
|
Substance Use and the Nervous System - Part 1
|
Jul 04, 2023 |
|
What’s New in Migraine? AHS Updates
|
Jun 30, 2023 |
|
Pivotal Stroke Trials Presented at this Year’s ESOC
|
Jun 29, 2023 |
|
Intracerebral Hemorrhage Trials
|
Jun 29, 2023 |
|
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
|
Jun 27, 2023 |
|
ARCADIA Trial
|
Jun 26, 2023 |
|
Economic Cost of Functional Neurologic Disorders: A Systematic Review
|
Jun 23, 2023 |
|
Racial and Ethnic Differences in Quality of Life in Parkinson Disease
|
Jun 22, 2023 |
|
Menstrual Migraine
|
Jun 21, 2023 |
|
SOS Minute: Autoimmune Encephalitis
|
Jun 20, 2023 |
|
Scalp-Negative Epileptic Seizures: Part 4
|
Jun 19, 2023 |
|
Diagnosis and Management of Migraine in Ten Steps
|
Jun 16, 2023 |
|
Subtle Clinical Signs in Unresponsive Brain Impairment
|
Jun 15, 2023 |
|
Scalp-Negative Epileptic Seizures: Part 3
|
Jun 14, 2023 |
|
Scalp-Negative Epileptic Seizures: Part 2
|
Jun 13, 2023 |
|
Scalp-Negative Epileptic Seizures: Part 1
|
Jun 12, 2023 |
|
Effects of Daylight Saving Time Shifts on Sleep Symptoms
|
Jun 09, 2023 |
|
Biomarkers of Spontaneous Intracranial Hypotension
|
Jun 08, 2023 |
|
Sudden Unexpected Death in Epilepsy - Part 3
|
Jun 07, 2023 |
|
Sudden Unexpected Death in Epilepsy - Part 2
|
Jun 06, 2023 |
|
Sudden Unexpected Death in Epilepsy - Part 1
|
Jun 05, 2023 |
|
N-Acetyl-L-Leucine in GM2 Gangliosidoses
|
Jun 02, 2023 |
|
α-Synuclein Seed Amplification in a Large Parkinson Cohort
|
Jun 01, 2023 |
|
New-Onset Refractory Status Epilepticus (NORSE) - Part 3
|
May 31, 2023 |
|
New-Onset Refractory Status Epilepticus (NORSE) - Part 2
|
May 30, 2023 |
|
New-Onset Refractory Status Epilepticus (NORSE) - Part 1
|
May 29, 2023 |
|
Somato-Cognitive Action Networks in Motor Cortex
|
May 26, 2023 |
|
Competencies for Postgraduate Training in Global Neurology
|
May 25, 2023 |
|
Inflammatory Activity After Diverse Fertility Treatments
|
May 25, 2023 |
|
Black Patients with Movement Disorders Less Likely to Receive Treatment with Deep Brain Stimulation
|
May 23, 2023 |
|
Botox Exposure During Pregnancy
|
May 22, 2023 |
|
FDA Approved Therapy for SOD1 Associated ALS
|
May 19, 2023 |
|
Neurologic Care of Forcibly Displaced Persons: Emerging Issues in Neurology
|
May 18, 2023 |
|
Treatment of Radiologically Isolated Syndrome
|
May 17, 2023 |
|
Mediterranean Diet is Associated with Cognition in Multiple Sclerosis
|
May 16, 2023 |
|
Diagnosis and Treatment of Cerebral Venous Thrombosis - Part 4
|
May 15, 2023 |
|
Diagnosis and Treatment of Cerebral Venous Thrombosis - Part 3
|
May 12, 2023 |
|
Diagnosis and Treatment of Cerebral Venous Thrombosis - Part 2
|
May 11, 2023 |
|
Diagnosis and Treatment of Cerebral Venous Thrombosis - Part 1
|
May 11, 2023 |
|
Seizure Forecasting and Detection
|
May 10, 2023 |
|
Biomarker and Treatment Development in Movement Disorders
|
May 09, 2023 |
|
Circadian Features of Cluster Headache and Migraine
|
May 08, 2023 |
|
How Udall Centers Support PD Research
|
May 05, 2023 |
|
Follow-up of Ultrasound Subthalamotomy for Parkinson Disease
|
May 04, 2023 |
|
Reliability of Unsupervised Digital Cognitive Assessment
|
May 02, 2023 |
|
Life Stressors During Pregnancy in Women With Epilepsy
|
May 02, 2023 |
|
CT Perfusion vs CT for Late Window Stroke Thrombectomy
|
Apr 28, 2023 |
|
Respiratory Strength Training in ALS
|
Apr 27, 2023 |
|
Cervical Artery Dissection - Part 3
|
Apr 26, 2023 |
|
Cervical Artery Dissection - Part 2
|
Apr 25, 2023 |
|
Cervical Artery Dissection - Part 1
|
Apr 24, 2023 |
|
How Teens Recovered From the ‘TikTok Tics’ - The New York Times
|
Apr 21, 2023 |
|
Disease Course and Long-term Outcomes in Pregnant Women With Idiopathic Intracranial Hypertension
|
Apr 21, 2023 |
|
Meet the Neurology Minute Editors!
|
Apr 19, 2023 |
|
Global Neurological Care
|
Apr 18, 2023 |
|
No Ordinary Campaign: A Documentary on ALS and our Broken Healthcare System
|
Apr 17, 2023 |
|
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
|
Apr 14, 2023 |
|
Mechanical Thrombectomy for Acute Ischemic Stroke - Part 3
|
Apr 13, 2023 |
|
Mechanical Thrombectomy for Acute Ischemic Stroke - Part 2
|
Apr 12, 2023 |
|
Mechanical Thrombectomy for Acute Ischemic Stroke - Part 1
|
Apr 11, 2023 |
|
Neighborhood Social Determinants of Health in Patients Seen in Neurology Movement Disorders Clinics
|
Apr 10, 2023 |
|
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia
|
Apr 07, 2023 |
|
Support for People with Chronic Headaches and Migraine
|
Apr 06, 2023 |
|
Factors Mediating Public Perceptions of Therapeutic Closed-Loop Brain Implants for Epilepsy and Mood Disorders
|
Apr 05, 2023 |
|
Hot Cross Bun Sign (HCBS)
|
Apr 04, 2023 |
|
Neuromodulation of the Vagus Nerve
|
Apr 03, 2023 |
|
A Discussion with Dr. Saylor: Ted Burns Humanism Award Winner
|
Mar 31, 2023 |
|
Links Between Pain & Depression with Unemployment Due to CNS Cancer
|
Mar 30, 2023 |
|
Neuroimaging in Adults and Children With Epilepsy - Part 3
|
Mar 29, 2023 |
|
Neuroimaging in Adults and Children With Epilepsy - Part 2
|
Mar 28, 2023 |
|
Neuroimaging in Adults and Children With Epilepsy - Part 1
|
Mar 27, 2023 |
|
Ralph Sacco: In Memoriam
|
Mar 24, 2023 |
|
Specific Surgical Techniques at the National Association of Epilepsy Centers
|
Mar 23, 2023 |
|
Immune Effector Cell-Associated Neurotoxicity Syndrome - Part 2
|
Mar 22, 2023 |
|
Immune Effector Cell-Associated Neurotoxicity Syndrome - Part 1
|
Mar 21, 2023 |
|
Anti-LGI4 Antibody: Novel Cause of an Autoimmune Nodopathy
|
Mar 20, 2023 |
|
Modern Neurology Training Is Failing Outpatients
|
Mar 17, 2023 |
|
Hematopoietic Stem Cell Transplant In Secondary Progressive MS
|
Mar 16, 2023 |
|
History of the First Women Neurologists and Scientists who Participated in the Development of the AAN
|
Mar 15, 2023 |
|
History of Match Day
|
Mar 14, 2023 |
|
Should Clinicians Reconsider Classifying MS As Relapsing or Progressive
|
Mar 13, 2023 |
|
Update on Cluster Headache Genetics
|
Mar 10, 2023 |
|
Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
|
Mar 09, 2023 |
|
Imaging of Brain Tumors: Part 3
|
Mar 08, 2023 |
|
Imaging of Brain Tumors: Part 2
|
Mar 07, 2023 |
|
Imaging of Brain Tumors: Part 1
|
Mar 06, 2023 |
|
Study of Vaccine-Based Therapy for GBM
|
Mar 03, 2023 |
|
Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
|
Mar 02, 2023 |
|
Supporting Medical Research and Care
|
Mar 01, 2023 |
|
Overly Burdensome Barriers to Care
|
Feb 28, 2023 |
|
Reforms to the Medicare Payment System
|
Feb 27, 2023 |
|
EAN/PNS CIDP Guideline
|
Feb 24, 2023 |
|
A Parent-Informed Approach to Communicating Neurological Prognosis in Infants
|
Feb 23, 2023 |
|
Imaging of Central Nervous System Ischemia - Part 3
|
Feb 22, 2023 |
|
Imaging of Central Nervous System Ischemia - Part 2
|
Feb 21, 2023 |
|
Imaging of Central Nervous System Ischemia - Part 1
|
Feb 20, 2023 |
|
An Update on Cluster Headache Treatment Options
|
Feb 17, 2023 |
|
Racial and Ethnic Differences in Antiseizure Medication
|
Feb 16, 2023 |
|
Careers in Neurology: Neuroethics
|
Feb 15, 2023 |
|
Careers in Neurology: Fellowships
|
Feb 14, 2023 |
|
Multimorbidity in Cluster Headache Patients
|
Feb 13, 2023 |
|
Amyloid Changes in Individuals with Down Syndrome versus Alzheimer's Disease
|
Feb 10, 2023 |
|
CSF Flow and Spinal Cord Motion in Patients With Spontaneous Intracranial Hypotension
|
Feb 09, 2023 |
|
Management of Neuropsychiatric Symptoms in Dementia
|
Feb 08, 2023 |
|
Careers in Neurology: Editorial Board
|
Feb 07, 2023 |
|
Blood Patch for Patients with CSF Leak
|
Feb 06, 2023 |
|
Dementia and Mild Cognitive Impairment
|
Feb 03, 2023 |
|
Mimics of Pediatric Small Vessel Primary Angiitis of the Central Nervous System
|
Feb 02, 2023 |
|
Continuum: Inflammatory Myopathies: Part 3
|
Feb 01, 2023 |
|
Continuum: Inflammatory Myopathies: Part 2
|
Jan 31, 2023 |
|
Continuum: Inflammatory Myopathies: Part 1
|
Jan 30, 2023 |
|
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
|
Jan 27, 2023 |
|
Sex-Specific Protective Effects of Cognitive Reserve on Age-Related Cognitive Decline
|
Jan 26, 2023 |
|
Climate Change and Neurologic Disorders
|
Jan 25, 2023 |
|
Folic Acid and Epilepsy
|
Jan 24, 2023 |
|
Genetic Optic Neuropathy
|
Jan 23, 2023 |
|
Natural Language Processing and Impact on the Career of Neurology and Publication
|
Jan 20, 2023 |
|
Diagnosis of Functional Seizures on Health Care Costs
|
Jan 19, 2023 |
|
Neuromuscular Weakness - Part 3
|
Jan 18, 2023 |
|
Neuromuscular Weakness - Part 2
|
Jan 17, 2023 |
|
Neuromuscular Weakness - Part 1
|
Jan 16, 2023 |
|
Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients Receiving CAR-T Therapy for Cancer
|
Jan 13, 2023 |
|
Gender Disparities in the Career of Neurology Researchers
|
Jan 12, 2023 |
|
Careers in Neurology: Clinical Trialist
|
Jan 11, 2023 |
|
Minute for Migraine: Capturing the Diagnosis (Aura vs. TIA)
|
Jan 11, 2023 |
|
Minute for Migraine: Capturing the Migraine Diagnosis
|
Jan 10, 2023 |
|
Careers in Neurology: Clinical Trialist
|
Jan 09, 2023 |
|
Incidence of Status Migrainosus
|
Jan 06, 2023 |
|
Neuro-Ophthalmology Approaches to Headache Disorders - Part 2
|
Jan 05, 2023 |
|
Neuro-Ophthalmology Approaches to Headache Disorders - Part 1
|
Jan 04, 2023 |
|
Hydroxychloroquine Toxicity
|
Jan 03, 2023 |
|
Diagnostic Evaluation of Creutzfeldt-Jakob Disease
|
Jan 02, 2023 |
|
Lecanemab in Early Alzheimer’s Disease
|
Dec 30, 2022 |
|
Efficacy of Diet on Fatigue and Quality of Life in MS
|
Dec 29, 2022 |
|
2022 Advocacy Update - Part 2
|
Dec 28, 2022 |
|
2022 Advocacy Update - Part 1
|
Dec 27, 2022 |
|
GATA2 Deficiency
|
Dec 26, 2022 |
|
Autoimmune Encephalitis Misdiagnosis in Adults
|
Dec 23, 2022 |
|
Levodopa Response in Patients with Early Parkinson Disease
|
Dec 22, 2022 |
|
Glioma Occurrence and Symptomatology
|
Dec 21, 2022 |
|
A Minute for Migraine: The Migraine Diagnosis
|
Dec 20, 2022 |
|
Young Onset Dementias
|
Dec 19, 2022 |
|
Link Between Gut and Parkinson's Disease
|
Dec 16, 2022 |
|
MRI-Visible Perivascular Spaces and Risk of Incident Dementia
|
Dec 15, 2022 |
|
Chorea - Part 3
|
Dec 14, 2022 |
|
Chorea - Part 2
|
Dec 13, 2022 |
|
Chorea - Part 1
|
Dec 12, 2022 |
|
Rituximab for New-Onset Generalized Myasthenia Gravis
|
Dec 09, 2022 |
|
Interfacility Transfers for Seizure-Related Emergencies
|
Dec 08, 2022 |
|
Epilepsy Risk Following Bariatric Surgery for Weight Loss
|
Dec 07, 2022 |
|
Recap from 2022 Interim Meeting of the AMA House of Delegates
|
Dec 06, 2022 |
|
Genetic Testing in Dementia
|
Dec 05, 2022 |
|
Risk of Suicide After Dementia Diagnosis
|
Dec 02, 2022 |
|
Creutzfeldt-Jakob Disease Mimics
|
Dec 01, 2022 |
|
Surgical Management of Essential Tremor
|
Nov 30, 2022 |
|
Medicare Physician Fee Schedule - Reaction to Final Rule
|
Nov 29, 2022 |
|
Medicare Physician Fee Schedule - Final Rule Update
|
Nov 28, 2022 |
|
African Academy of Neurology (AFAN) Annual Meeting
|
Nov 25, 2022 |
|
Update on Migraine Guidelines
|
Nov 25, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 9
|
Nov 23, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 8
|
Nov 23, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 7
|
Nov 21, 2022 |
|
The ALS Strategic Plan from NINDS
|
Nov 18, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 6
|
Nov 16, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 5
|
Nov 15, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 4
|
Nov 14, 2022 |
|
CGRP and Role of Sex Hormones
|
Nov 11, 2022 |
|
Pre-Hospital Evaluation of Acute Stroke: EMS vs Telemed
|
Nov 10, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 3
|
Nov 09, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 2
|
Nov 08, 2022 |
|
Parkinson's Disease and Parkinsonism - Part 1
|
Nov 07, 2022 |
|
Headache Classification for the Busy Neurologists
|
Nov 04, 2022 |
|
GPNMB Confers Risk for Parkinson’s Disease
|
Nov 03, 2022 |
|
Neurodegenerative Cerebellar Ataxia - Part 3
|
Nov 02, 2022 |
|
Neurodegenerative Cerebellar Ataxia - Part 2
|
Nov 01, 2022 |
|
Neurodegenerative Cerebellar Ataxia - Part 1
|
Oct 31, 2022 |
|
Neurology Education: Check it out!
|
Oct 28, 2022 |
|
Progressive Supranuclear Palsy and Corticobasal Syndrome - Part 3
|
Oct 26, 2022 |
|
Progressive Supranuclear Palsy and Corticobasal Syndrome - Part 2
|
Oct 25, 2022 |
|
Progressive Supranuclear Palsy and Corticobasal Syndrome - Part 1
|
Oct 24, 2022 |
|
Clinicopathologic Correlations of Jaw Tremor
|
Oct 21, 2022 |
|
Retinal and Cortical Atrophy in MS
|
Oct 20, 2022 |
|
Global Burden of Migraine - Part 3
|
Oct 19, 2022 |
|
Global Burden of Migraine - Part 2
|
Oct 18, 2022 |
|
Global Burden of Migraine - Part 1
|
Oct 17, 2022 |
|
Ketamine in Pediatric Status Epilepticus
|
Oct 14, 2022 |
|
Diagnosing Pre-Motor Multiple System Atrophy
|
Oct 13, 2022 |
|
Emerging Infectious Diseases - Part 3
|
Oct 12, 2022 |
|
Emerging Infectious Diseases - Part 2
|
Oct 11, 2022 |
|
Emerging Infectious Diseases - Part 1
|
Oct 10, 2022 |
|
Acute Flaccid Myelitis or Polio - Signs and Symptoms
|
Oct 08, 2022 |
|
Genetic CNS Disease Masquerading as Neuroinflammatory Disorders
|
Oct 06, 2022 |
|
Cardiac Risks of Anti-Seizure Medications
|
Oct 05, 2022 |
|
Spiky Series - Folic Acid Supplementation
|
Oct 04, 2022 |
|
Leadership Skills for Neurologists
|
Oct 03, 2022 |
|
AED Duotherapy in Patient With Glioma
|
Sep 30, 2022 |
|
Outcomes of Endovascular Therapy for Stroke with Large Ischemic Core
|
Sep 29, 2022 |
|
Dizziness & Vertigo
|
Sep 28, 2022 |
|
Spiky Series - Neuroimaging in Patients with First Seizure
|
Sep 27, 2022 |
|
Neuromyelitis Optica Spectrum Disorder
|
Sep 26, 2022 |
|
ECG-Gated Cardiac CT in Acute Ischemic Stroke vs Transthoracic Echocardiography
|
Sep 24, 2022 |
|
Next-Generation Sequencing for Diagnosis of Central Nervous System Infections
|
Sep 23, 2022 |
|
Neurological Manifestations of Systemic Disease Autoimmunity
|
Sep 21, 2022 |
|
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Mountain West
|
Sep 20, 2022 |
|
Neuromyelitis Optica Spectrum Disorder in Clinical Practice
|
Sep 20, 2022 |
|
Preceding Infections in Guillain-Barré Syndrome
|
Sep 16, 2022 |
|
Impact of Weight Loss in IIH
|
Sep 15, 2022 |
|
Psychiatric Symptoms in Autoimmune Encephalitis Remission
|
Sep 14, 2022 |
|
Broadening the Differential of Autoimmune Encephalitis
|
Sep 13, 2022 |
|
Neurosarcoidosis
|
Sep 12, 2022 |
|
Different Motor Features of Genetic FTLD
|
Sep 09, 2022 |
|
IVIg Maintenance Therapy in GAD+ Stiff-Person Syndrome
|
Sep 08, 2022 |
|
Stiff Person Syndrome - Part 3
|
Sep 07, 2022 |
|
Stiff Person Syndrome - Part 2
|
Sep 06, 2022 |
|
Stiff Person Syndrome - Part 1
|
Sep 05, 2022 |
|
Biomarkers for DBS Optimization in Movement Disorders
|
Sep 02, 2022 |
|
Dementia and Palliative Care
|
Sep 01, 2022 |
|
Careers in Neurology: Medical Education
|
Aug 31, 2022 |
|
Vincristine-Induced Neuropathy
|
Aug 30, 2022 |
|
2023 Medicare Physician Fee Schedule Proposed Rule
|
Aug 29, 2022 |
|
Thrombectomy Alone vs IV Alteplase Plus Thrombectomy in Stroke
|
Aug 26, 2022 |
|
Determining Clinical Meaningfulness in Dementia
|
Aug 25, 2022 |
|
Treatment of Multiple Sclerosis: Part 3
|
Aug 24, 2022 |
|
Treatment of Multiple Sclerosis: Part 2
|
Aug 23, 2022 |
|
Treatment of Multiple Sclerosis: Part 1
|
Aug 22, 2022 |
|
Histiocytic Diseases Affecting the Central Nervous System
|
Aug 19, 2022 |
|
Predicting Outcomes Among Patients Undergoing Intracranial EEG
|
Aug 18, 2022 |
|
Myelin Oligodendrocyte Glycoprotein–Associated Disorders - Part 3
|
Aug 17, 2022 |
|
Myelin Oligodendrocyte Glycoprotein–Associated Disorders - Part 2
|
Aug 16, 2022 |
|
Myelin Oligodendrocyte Glycoprotein–Associated Disorders - Part 1
|
Aug 15, 2022 |
|
Young-Onset Ischemic Stroke Risk Factors in Black and White Individuals
|
Aug 12, 2022 |
|
Perceptions vs Experience for Patients Undergoing Lumbar Puncture
|
Aug 11, 2022 |
|
Diagnosis of Multiple Sclerosis - Part 3
|
Aug 10, 2022 |
|
Diagnosis of Multiple Sclerosis - Part 2
|
Aug 09, 2022 |
|
Diagnosis of Multiple Sclerosis - Part 1
|
Aug 08, 2022 |
|
Alpha-Synuclein Amplification for Disease Diagnosis
|
Aug 05, 2022 |
|
The WHO Brain Health Unit
|
Aug 04, 2022 |
|
Racial, Ethnic Disparities in Multiple Sclerosis Prevalence
|
Aug 02, 2022 |
|
Chronic Headaches and Warning Signs
|
Aug 01, 2022 |
|
Adverse Childhood Experiences and Neurologic Conditions
|
Jul 29, 2022 |
|
Genetics and the Age-at-Onset in Parkinson's Disease
|
Jul 28, 2022 |
|
Recurrence of TGA
|
Jul 27, 2022 |
|
Continuum: Cognitive Syndromes Associated With Movement Disorders - Part 2
|
Jul 26, 2022 |
|
Continuum: Cognitive Syndromes Associated With Movement Disorders - Part 1
|
Jul 25, 2022 |
|
Continuum: Dementia
|
Jul 22, 2022 |
|
Positive Airway Pressure and Cognitive Disorders in OSA
|
Jul 21, 2022 |
|
Social Isolation and Dementia
|
Jul 20, 2022 |
|
Genome-Wide Migraine Study - Part 2
|
Jul 19, 2022 |
|
Genome-Wide Migraine Study - Part 1
|
Jul 18, 2022 |
|
Runner's Dystonia
|
Jul 15, 2022 |
|
Psychiatric Co-Morbidities of Idiopathic Intracranial Hypertension
|
Jul 14, 2022 |
|
Continuum: Alzheimer Disease - Part 3
|
Jul 13, 2022 |
|
Continuum: Alzheimer Disease - Part 2
|
Jul 12, 2022 |
|
Continuum: Alzheimer Disease - Part 1
|
Jul 11, 2022 |
|
Careers in Neurology: Health Services Research
|
Jul 08, 2022 |
|
Maternal Serotonergic Antidepressant Use in Pregnancy and Risk of Seizures in Children
|
Jul 07, 2022 |
|
Ted Burns: A Podcast In Memoriam
|
Jul 06, 2022 |
|
Optic Nerve MRI
|
Jul 05, 2022 |
|
GABAa Encephalitis
|
Jul 04, 2022 |
|
Antisense Oligonucleotide Suppression of Mutant C9orf72
|
Jul 01, 2022 |
|
Cognitive Syndromes Associated with COVID
|
Jun 30, 2022 |
|
The Value of Neuroimaging in Dementia Diagnosis - Part 3
|
Jun 29, 2022 |
|
The Value of Neuroimaging in Dementia Diagnosis - Part 2
|
Jun 28, 2022 |
|
The Value of Neuroimaging in Dementia Diagnosis - Part 1
|
Jun 27, 2022 |
|
Careers in Neurology: Clinical Development
|
Jun 24, 2022 |
|
Corticosteroids in LGI1 Antibody Encephalitis
|
Jun 23, 2022 |
|
NINDS Mission and Clinical Neurology with Walter Koroshetz
|
Jun 22, 2022 |
|
Neurosarcoidosis - Part 2
|
Jun 21, 2022 |
|
Neurosarcoidosis - Part 1
|
Jun 20, 2022 |
|
Maintenance Intravenous Immunoglobulin Prevents Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
|
Jun 17, 2022 |
|
Medicare Limitation of Aduhelm
|
Jun 16, 2022 |
|
EEG Patterns and Neurofilament Light After Cardiac Arrest
|
Jun 15, 2022 |
|
Adult Opsoclonus-Myoclonus Syndrome
|
Jun 14, 2022 |
|
Pediatric Opsoclonus-Myoclonus Syndrome
|
Jun 13, 2022 |
|
Early Detection of Parkinson’s Disease
|
Jun 10, 2022 |
|
Race-Ethnic Disparities in Stroke Thrombolysis
|
Jun 09, 2022 |
|
A Review of L-arginine in MELAS
|
Jun 08, 2022 |
|
Post-Concussion Headache
|
Jun 07, 2022 |
|
Development of New or Enlarging MRI Lesions Rare in MOGAD
|
Jun 06, 2022 |
|
Fentanyl Exposure
|
Jun 03, 2022 |
|
Pure Sleep Epilepsy in Patients With First Seizure
|
Jun 02, 2022 |
|
Quality of Life for Patients with Parkinson's Disease
|
Jun 01, 2022 |
|
Continuum: Epilepsy
|
May 31, 2022 |
|
Acute Symptomatic Seizures Secondary to MOGAD
|
May 31, 2022 |
|
Neurodegeneration in Pro Football Players - Part 2
|
May 27, 2022 |
|
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia In Children
|
May 26, 2022 |
|
Neurology on the Hill: Telehealth
|
May 25, 2022 |
|
Neurology on the Hill: Barriers to Care
|
May 24, 2022 |
|
Neurology on the Hill: Support the Neurology Workforce
|
May 23, 2022 |
|
The High Cost of Multiple Sclerosis
|
May 20, 2022 |
|
Neurodegeneration in Pro Football Players
|
May 19, 2022 |
|
Peripheral Neuropathy Evaluations of Patients with Prolonged Long COVID
|
May 18, 2022 |
|
Approach to the Medical Treatment of Epilepsy - Part 2
|
May 17, 2022 |
|
Approach to the Medical Treatment of Epilepsy - Part 1
|
May 16, 2022 |
|
Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy
|
May 13, 2022 |
|
Neuromodulation Restores Function in Spinal Cord Injury
|
May 11, 2022 |
|
Cardiac Arrhythmia in Patients with Drug-Resistant Epilepsy
|
May 11, 2022 |
|
Genetics and Neuroinflammation, Considerations for the Clinician - Part 4
|
May 10, 2022 |
|
Genetics and Neuroinflammation, Considerations for the Clinician - Part 3
|
May 09, 2022 |
|
PNES Semiology
|
May 06, 2022 |
|
Prognosis and Treatment of Spinal Cord Sarcoidosis
|
May 05, 2022 |
|
Cost Burden of MS in the U.S.
|
May 04, 2022 |
|
Genetics and Neuroinflammation, Considerations for the Clinician - Part 2
|
May 03, 2022 |
|
Genetics and Neuroinflammation, Considerations for the Clinician - Part 1
|
May 02, 2022 |
|
Combined Prophylactic Treatment of Chronic Migraine
|
Apr 29, 2022 |
|
Sudden Death and Cardiac Arrhythmia with Lamotrigine
|
Apr 28, 2022 |
|
Cognitive Decline in Patients with Parkinson's disease
|
Apr 27, 2022 |
|
Evaluation of First Seizure and Newly Diagnosed Epilepsy - Part 2
|
Apr 26, 2022 |
|
Evaluation of First Seizure and Newly Diagnosed Epilepsy - Part 1
|
Apr 25, 2022 |
|
Management of Stroke due to ICAD
|
Apr 22, 2022 |
|
Amyloid Treatments for Alzheimer Disease
|
Apr 21, 2022 |
|
Priorities from the 2022 ADRD Summit with Walter Koroshetz
|
Apr 20, 2022 |
|
Pre-pregnancy Migraine and Risk of Adverse Pregnancy Outcomes
|
Apr 19, 2022 |
|
Teleneurology Reduces Wait Time
|
Apr 18, 2022 |
|
Spinal Cord Stimulation for Painful Diabetic Neuropathy
|
Apr 15, 2022 |
|
GBM and Lomustine
|
Apr 14, 2022 |
|
Neurologic Causes of Post-Partum Readmission
|
Apr 13, 2022 |
|
Neuropsychiatric and Cognitive Comorbidities in Epilepsy - Part 2
|
Apr 12, 2022 |
|
Neuropsychiatric and Cognitive Comorbidities in Epilepsy - Part 1
|
Apr 11, 2022 |
|
Careers in Neurology: Neuroinformatics
|
Apr 08, 2022 |
|
Genetic Testing of White Matter Disorders
|
Apr 07, 2022 |
|
Patient Centered Treatment of Migraine with Medication Overuse
|
Apr 06, 2022 |
|
Magnetic Resonance Imaging Criteria at Onset to Differentiate Pediatric MS from Acute Disseminated Encephalomyelitis
|
Apr 05, 2022 |
|
Mortality and One-Year Readmission Rates Following Hospital Discharge in a Large Canadian Cerebral Venous Thrombosis Cohort
|
Apr 04, 2022 |
|
Association Between Cancer and Guillain-Barré Syndrome
|
Apr 01, 2022 |
|
Spinal Muscular Atrophy
|
Mar 31, 2022 |
|
Neuro-respiratory Criteria for Death Determination
|
Mar 30, 2022 |
|
LGI1 Antibody Encephalitis
|
Mar 29, 2022 |
|
Careers in Neurology: Transcranial Stimulation
|
Mar 28, 2022 |
|
Neurology of Pregnancy
|
Mar 25, 2022 |
|
Cognitive Outcomes in mTBI
|
Mar 24, 2022 |
|
ARIA Associated with Aducanumab
|
Mar 23, 2022 |
|
Epilepsy & Pregnancy - Part 2
|
Mar 22, 2022 |
|
Epilepsy & Pregnancy - Part 1
|
Mar 21, 2022 |
|
Costs and Health-Related Quality of Life in Patients with NMOSD and MOGAD
|
Mar 18, 2022 |
|
CSF Biomarkers in FTD and Alzheimer Disease
|
Mar 17, 2022 |
|
2022 Ted Burns Humanism in Neurology Award
|
Mar 16, 2022 |
|
Group A Streptococcal Infections and Onset of Tics
|
Mar 15, 2022 |
|
Number and Severity of Strokes Increase Risk for Dementia
|
Mar 14, 2022 |
|
Careers in Neurology: Teleneurology and Telestroke
|
Mar 11, 2022 |
|
Retinal Neuronal Loss in Optic Neuritis
|
Mar 10, 2022 |
|
Prevalence of Epstein-Barr Virus Associated with Multiple Sclerosis
|
Mar 09, 2022 |
|
Neuro-ophthalmology and Pregnancy - Part 2
|
Mar 08, 2022 |
|
Neuro-ophthalmology and Pregnancy - Part 1
|
Mar 07, 2022 |
|
Transition of Care From Pediatric To Adult Epilepsy Care
|
Mar 04, 2022 |
|
Generic Competition for Dimethyl Fumarate
|
Mar 03, 2022 |
|
Equal Pay for Women Neurologists: Show us the Money!
|
Mar 02, 2022 |
|
Medication overuse headache
|
Mar 01, 2022 |
|
Careers in Neurology: Global Health
|
Feb 28, 2022 |
|
POEMS Syndrome: A CIDP Mimicker
|
Feb 25, 2022 |
|
Variations in Seizure Frequency During Pregnancy and Postpartum
|
Feb 24, 2022 |
|
Migraine, Stroke, and Cervical Arterial Dissection and their Shared Genetics
|
Feb 23, 2022 |
|
Multigene Panel Testing In Adults With Epilepsy
|
Feb 22, 2022 |
|
Diagnosis & Management of Meningiomas
|
Feb 21, 2022 |
|
Glial Fibrillary Acidic Protein Autoimmunity
|
Feb 18, 2022 |
|
Pharmacy Benefits and Disease-Modifying Therapies
|
Feb 17, 2022 |
|
Maternal Stroke Associated with Pregnancy - Part 2
|
Feb 16, 2022 |
|
Maternal Stroke Associated with Pregnancy - Part 1
|
Feb 15, 2022 |
|
2022 AAN Annual Meeting Update
|
Feb 14, 2022 |
|
Surfer's Myelopathy
|
Feb 11, 2022 |
|
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus Score
|
Feb 10, 2022 |
|
Twilight and Me: A Soliloquy
|
Feb 09, 2022 |
|
Neurology Compensation Pay Gaps
|
Feb 08, 2022 |
|
Treatment of Sialorrhea
|
Feb 07, 2022 |
|
Kuru Disease
|
Feb 04, 2022 |
|
Oral and Topical Treatment of Painful Diabetic Polyneuropathy Practice Guideline Update Summary
|
Feb 03, 2022 |
|
CMS Proposal for Aducanumab
|
Feb 02, 2022 |
|
Hypertension Is an Associated Risk Factor for Late-Onset Epilepsy
|
Feb 01, 2022 |
|
Beyond Pain in Migraine Treatments
|
Jan 31, 2022 |
|
Behavioral Neurology and Psychiatry
|
Jan 28, 2022 |
|
Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement
|
Jan 27, 2022 |
|
Teen girls and new-onset tics - is TikTok playing a role?
|
Jan 26, 2022 |
|
Posttraumatic Stress Disorder and Anxiety-Related Conditions - Part 2
|
Jan 25, 2022 |
|
Posttraumatic Stress Disorder and Anxiety-Related Conditions - Part 1
|
Jan 24, 2022 |
|
Epilepsy-Related Mortality in Children and Young Adults in Denmark: A Nationwide Cohort Study
|
Jan 21, 2022 |
|
Functional Outcome, Recanalization, and Hemorrhage Rates After Large Vessel Occlusion Stroke Treated With Tenecteplase Before Thrombectomy
|
Jan 20, 2022 |
|
Approach to adult onset chorea - Part 5
|
Jan 19, 2022 |
|
Approach to Adult Onset Chorea - Part 4
|
Jan 18, 2022 |
|
Approach to Adult Onset Chorea - Part 3
|
Jan 17, 2022 |
|
Approach to Adult Onset Chorea - Part 2
|
Jan 14, 2022 |
|
Approach to Adult Onset Chorea - Part 1
|
Jan 13, 2022 |
|
Association between Anatomical Location of Epilepsy Surgery and Outcomes
|
Jan 12, 2022 |
|
The Amyloid Hypothesis for Alzheimer's disease and Aducanumab
|
Jan 11, 2022 |
|
Update on Vaccine-induced Immune Thrombotic Thrombocytopenia
|
Jan 10, 2022 |
|
Careers in Neurology: Neurocritical Care
|
Jan 07, 2022 |
|
Psychosis - Part 2
|
Jan 06, 2022 |
|
Psychosis - Part 1
|
Jan 05, 2022 |
|
White Matter MRI Sequelae of Repetitive Head Impacts
|
Jan 04, 2022 |
|
Antiseizure Medication Withdrawal
|
Jan 03, 2022 |
|
Endovascular Thrombectomy in Pregnant or Postpartum Patients
|
Dec 31, 2021 |
|
Careers in Neurology: Endovascular Surgical Neuroradiology
|
Dec 30, 2021 |
|
Adherence to Antiseizure Medications vs Other Medications
|
Dec 29, 2021 |
|
2021 Advocacy Update - Part 2
|
Dec 28, 2021 |
|
2021 Advocacy Update - Part 1
|
Dec 27, 2021 |
|
Obesity and Brain Health
|
Dec 24, 2021 |
|
Upper Limb Apraxia - Part 2
|
Dec 23, 2021 |
|
Upper Limb Apraxia - Part 1
|
Dec 22, 2021 |
|
Enzyme-Inducing Antiseizure Drugs and Cardiovascular Disease - Part 2
|
Dec 21, 2021 |
|
Enzyme-Inducing Antiseizure Drugs and Cardiovascular Disease - Part 1
|
Dec 20, 2021 |
|
Fascinomas - Part 3
|
Dec 17, 2021 |
|
Fascinomas - Part 2
|
Dec 16, 2021 |
|
Fascinomas - Part 1
|
Dec 15, 2021 |
|
CNS Involvement in Hereditary Transthyretin Amyloidosis
|
Dec 14, 2021 |
|
Effectiveness of Initial Treatment for Infantile Spasms
|
Dec 13, 2021 |